ANTIOXDANT SYSTEMS AND AGE-RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
基本信息
- 批准号:3465679
- 负责人:
- 金额:$ 11.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-08-01 至 1994-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Age-related macular degeneration (AMD) is the leading cause of blindness
in the over 60 year old American population. Available evidence suggests
that AMD results from a deterioration in function of the retinal pigment
epithelium (RPE). the critical role played by the RPE in photoreceptor
debris digestion, the light-rich and oxygen-rich location of the RPE
which provides an environment for oxidative damage, and the accumulation
of fluorescent pigments in the RPE with aging probably stimulated by
oxidative processes combine to suggest oxidative damage as a potential
cause of AMD.
Antioxidant systems protect the RPE from the cellular damage that can be
induced by oxidative processes. Glutathione (GSH) is a naturally
occurring tripeptide which functions as an antioxidant by reacting with
free radicals and peroxides to limit nonenzymatic oxidative processes.
Through this detoxification, GSH plays a major role in protection against
oxidative injury from chemicals or other sources in many cell systems,
including the liver, lung, and kidney. Preliminary studies have
demonstrated that exogenous GSH can protect cultured human RPE cells from
oxidative injury. The aims of this proposal are to characterize the
ability of the RPE to transport and synthesize GSH, to determine how
these functions change with age, and to better understand the role of GSH
in the RPE defense against oxidative injury.
The ability of RPE cells to transport GSH will be measured by he uptake
of radiolabelled GSH. GSH transport will be characterized further by the
study of the sodium dependence, pH dependence, concentration dependence,
and specificity of the transport system. RPE synthesis of GSH will be
measured by using HPLC determination after depletion of intracellular GSH
with diethyl maleate (DEM) followed by incubation of cells with
radiolabelled amino acid precursors of GSH. The rates of GSH transport
and synthesis can be measured and compared with donor age.
Further insight into the role of GSH in macular degeneration will be
provided by with measurement of cell viability by trypan blue exclusion.
Cultured cells will then be supplemented by GSH or the amino acid
precursors to determine which better protects the RPE from oxidative
injury.
By understanding glutathione's role in protecting the retinal pigment
epithelium from oxidative injury, these studies will provide insights
into the pathogenesis of AMD and, possibly, suggest therapeutic direction
for this devastating disease.
视网膜相关性黄斑变性(AMD)是导致失明的主要原因
在60岁以上的美国人口中。 现有证据表明
AMD是由视网膜色素功能的恶化引起的,
上皮(RPE)。 RPE在光感受器中的关键作用
碎片消化,RPE的富光和富氧位置
它为氧化损伤和积累提供了环境
的荧光色素的RPE与老化可能刺激
氧化过程联合收割机表明氧化损伤是一种潜在的
AMD的原因
抗氧化系统保护RPE免受细胞损伤,
由氧化过程引起的。 谷胱甘肽(GSH)是一种天然的
存在的三肽,其通过与以下物质反应而起到抗氧化剂的作用:
自由基和过氧化物来限制非酶氧化过程。
通过这种解毒作用,GSH在保护机体免受
在许多细胞系统中来自化学品或其它来源的氧化损伤,
包括肝肺和肾 初步研究已经
证明外源性GSH可以保护培养的人RPE细胞免受
氧化损伤 本提案的目的是描述
RPE运输和合成GSH的能力,以确定如何
这些功能随着年龄的增长而变化,为了更好地了解GSH的作用,
在RPE防御氧化损伤中的作用。
RPE细胞转运GSH的能力将通过摄取来测量。
放射性标记的谷胱甘肽 GSH转运将进一步表征为
钠依赖性、pH依赖性、浓度依赖性
运输系统的特殊性。 视网膜色素上皮细胞合成谷胱甘肽
在细胞内GSH耗尽后使用HPLC测定来测量
用马来酸二乙酯(DEM)孵育细胞,
放射性标记的GSH的氨基酸前体。 GSH转运率
和合成可以被测量并与供体年龄进行比较。
进一步深入了解谷胱甘肽在黄斑变性中的作用,
通过台盼蓝拒染法测量细胞活力。
然后将培养的细胞补充GSH或氨基酸
前体以确定哪种更好地保护RPE免受氧化
损伤
通过了解谷胱甘肽在保护视网膜色素中的作用
这些研究将为我们提供
AMD的发病机制,并可能提出治疗方向
这种毁灭性的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL STERNBERG其他文献
PAUL STERNBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL STERNBERG', 18)}}的其他基金
AGN92013/ALRT1057 FOR RETINAL DETACHMENT DUE TO PROLIFERATIVE VITREORETINOPATHY
AGN92013/ALRT1057 用于治疗增殖性玻璃体视网膜病变引起的视网膜脱离
- 批准号:
6274426 - 财政年份:1997
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
2903135 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
6178983 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
2161755 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXDANT SYSTEMS AND AGE-RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
3465678 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
6637201 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
6525047 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATION
抗氧化系统和年龄相关性黄斑变性
- 批准号:
6384596 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
Antioxidant Systems and Age-related Macular Degeneration
抗氧化系统和年龄相关性黄斑变性
- 批准号:
7487754 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
Antioxidant Systems and Age-related Macular Degeneration
抗氧化系统和年龄相关性黄斑变性
- 批准号:
7289234 - 财政年份:1989
- 资助金额:
$ 11.25万 - 项目类别:
相似海外基金
Potential of Oxyresveratrol and other antioxidants to protect cells from trauma and aging
氧化白藜芦醇和其他抗氧化剂具有保护细胞免受创伤和衰老的潜力
- 批准号:
415301-2011 - 财政年份:2011
- 资助金额:
$ 11.25万 - 项目类别:
University Undergraduate Student Research Awards
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2002
- 资助金额:
$ 11.25万 - 项目类别:
Strategic Projects - Group
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2001
- 资助金额:
$ 11.25万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6359552 - 财政年份:2000
- 资助金额:
$ 11.25万 - 项目类别:
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2000
- 资助金额:
$ 11.25万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6218772 - 财政年份:1999
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6098816 - 财政年份:1999
- 资助金额:
$ 11.25万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6267774 - 财政年份:1998
- 资助金额:
$ 11.25万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8816010 - 财政年份:1997
- 资助金额:
$ 11.25万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8431784 - 财政年份:1997
- 资助金额:
$ 11.25万 - 项目类别:














{{item.name}}会员




